30 August 2018
Visiongain’s new report the Global Empty Capsules Market and Industry Forecast 2016-2026: Gelatin Capsules, Non-gelatin Capsules, Pig Skin Gelatin, Bovine Derived Gelatin, Bone Meal Gelatin, Hydroxypropyl Methyl Cellulose (HPMC), Pullulan, Starch Material indicates that the global Empty Capsules market will see $1,944m in spending in 2020.
The lead analyst of the report said: ““The hard gelatin capsules segment is the largest segment of the empty capsules market and will continue to dominate throughout the forecast period. However, this segment will lose market shares to non-gelatin capsules segment, dropping from 85.8% in 2015 to 84.5% in 2026
The non-gelatin capsules segment is estimated to grow with the highest CAGR during the forecast period. Strict government regulations, dietary sensitivity of patients, and drug incompatibilities with gelatin capsules are the major factors driving the growth of the non-gelatin capsules segment.”
The 286 page report contains 200 tables, charts and graphs that add visual analysis in order to explain developing trends within the Global Empty Capsules market. Visiongain provides revenue forecasts for the period 2016-2026 as well as qualitative analyses for the leading segments of this market, which include Gelatin Capsules and Non gelatine Capsules. The report also gives qualitative and quantitative analysis of the Global Empty Capsules market by type of material, therapeutic application and end user.
The 286 page report offers market forecasts and analysis for 12 leading national markets and the rest of the world market. In addition, the report contains a dedicated leading companies’ chapter covering 11 companies leading the field in Empty Capsules market.
The Global Empty Capsules Market and Industry Forecast 2016-2026: Gelatin Capsules, Non-gelatin Capsules, Pig Skin Gelatin, Bovine Derived Gelatin, Bone Meal Gelatin, Hydroxypropyl Methyl Cellulose (HPMC), Pullulan, Starch Material report will be of value to anyone who wants to better understand the Empty Capsules market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Empty Capsules industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
18 January 2021
Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.
08 January 2021
The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.
07 January 2021
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.